Model
Edge
Moonlake Immunotherapeutics
MLTX
Filing Type
8-K
Filing Date
6/24/2026
Updated
6/25/26, 4:20 AM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts
EX-1.1
UNDERWRITING AGREEMENT, DATED JUNE 23, 2026, BY AND BETWEEN MOONLAKE IMMUNOTHERAPEUTICS AND LEERINK PARTNERS LLC
EX-4.1
FORM OF PRE-FUNDED WARRANT
EX-5.1
OPINION OF WALKERS (CAYMAN) LLP
GRAPHIC
Graphic